Journal of Big Data Research

The Open Access Pub has the reputation for quick reviewing and publishing original research articles. The editorial boards of our journals have many dedicated and reputed scientists as editorial members. Their support helps many researchers from all countries to enhance their research between scientists of various communities. This platform plays a crucial role in promoting science networks and exchanges.

Dr. Gerald H. Lushington, CSO And Computational Chemistry Expert For Drug Discovery.

USA

Chief Scientific Officer (CSO)

ORCID: 0000-0001-5821-4253

Send an Email

Dr. Gerald H. Lushington

Address:

Qnapsyn Biosciences Inc., USA , Kansas State University


Academic Profiles

Explore his academic and professional presence across trusted platforms:

  • h-index: 46
  • i-10 index: 130
  • Total Citations: 6140

Research Interests:

  • Computational Chemistry And Cheminformatics
  • Artificial Intelligence (AI) For Drug Discovery
  • Neurological And Immunological Therapeutic Development
  • High Throughput Screening (HTS)
  • Molecular Science And Chemical Databases

Biography:

Dr. Gerald H. Lushington is a highly prolific scientist with a deep background in Computational Chemistry and Cheminformatics. His research involves applying Artificial Intelligence (AI) and bio-inspired methods to accelerate drug discovery, focusing on developing immunotherapeutic and neurological drug candidates. He specializes in the design and implementation of chemical databases and software tools crucial for efficient preclinical pharmaceutical research. He plays a key role in academic publishing as the Editor-In-Chief of a specialized high-throughput screening journal.
 

Education Details:
  • PhD (Chemistry): University Of New Brunswick, Canada (1995).

Professional Background:
  • Chief Scientific Officer (CSO) (Current) - Qnapsyn Biosciences Inc.
  • Courtesy Appointment - Kansas State University.
     
Achievements:
  • Led development of technological bases and pipelines for neurological therapeutic intervention.
  • Published extensively across diverse areas of molecular science and data analysis.
     
Current Research Projects:
  • AI For Drug Discovery: Application of artificial intelligence and bioinspiration for developing new drug candidates.
  • Therapeutic Development: Identifying core neuromedical mechanisms and developing protocols for immunotherapeutic and neurological drugs.​
     
Academic Profiles Of Dr. Gerald H. Lushington

Explore his academic and professional presence across trusted platforms:

Publications:

Dr. Lushington’s publishing efforts reflect his expertise in data-driven pharmaceutical science, focusing on chemical informatics, database resources, and drug design.

The list of recent publications of Dr. Gerald H. Lushington is listed below:

  • Lushington, T. H. W., & Lushington, G. H. (2023). Basic Information Science Methods for Insight into Neurodegenerative Pathogenesis. Book Chapter.
  • Lushington, G. H. (2023). Chemical informatics and the drug discovery knowledge pyramid. Future Medicinal Chemistry, 5(9), 1017-1025. DOI: 10.4155/fmc.13.56.
  • Lushington, G. H. (2023). Chemical Database Resources: Tools for Preclinical Drug Discovery. Expert Opinion on Drug Discovery, 8(4), 437-448. DOI: 10.1517/17460441.2013.774431.
  • Jupe, E. R., Lushington, G. H., Purushothaman, M., & Wang, B. (2022). Automated Compound Library Annotation and Curation for High Throughput Screening. Combinatorial Chemistry & High Throughput Screening, 25(3), 395-405.
  • Zhiwei, Y., & Lushington, G. H. (2022). Computational Approaches for Hit-to-Lead Optimization in Drug Discovery. Current Topics in Medicinal Chemistry, 22(1), 77-88.

 


Last Updated on September 29, 2025